scCANCER
scCANCER integrates new biophysical and genomic technologies to study this plasticity and slow the progression of metastatic breast cancer.
The plasticity of tumor cells allows their evolution towards aggressive states escaping available therapies.
In scCANCER we integrate analysis of genomic and biochemical studies with the analysis of the biophysical properties that accompany tumor progression towards more aggressive and resistant states to current therapies. This integration has never been done before and may represent a qualitative change that will allow new therapeutic strategies for the most aggressive tumors.
Latest News
Javier Tamayo is among the 2% of the most cited researchers in the world
3 de noviembre de 2023
Read more >
